NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
20.19
-1.06 (-4.99%)
At close: Oct 13, 2026, 4:00 PM EDT
20.20
+0.01 (0.05%)
After-hours: Oct 13, 2026, 7:05 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $2.41 billion as of October 13, 2026. It is the 5,770th most valuable company in the world and the 1,619th biggest in the United States. Its market cap has decreased by 42.16% in one year.
Market Cap
2.41B
Enterprise Value
1.74B
1-Year Change
-42.16%
Global Rank
Country Rank
#1,619 United States
Category
ChartMarket Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.41B, an increase of 1,462.62%. That is a compound annual growth rate of 62.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 2.41B | -39.33% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 2.81B |
| Precigen | 2.80B |
| Beam Therapeutics | 2.57B |
| MBX Biosciences | 2.56B |
| Disc Medicine | 2.38B |
| SELLAS Life Sciences Group | 2.35B |
| Celldex Therapeutics | 2.35B |
| Harmony Biosciences Holdings | 2.35B |